Lung Transplant Clinical Trial
Official title:
The Role Of Endoscopic Alveoscopy by Confocal Endomicroscopy in Diagnosing Acute and Chronic Rejection in Lung Transplant Recipients, Diagnosis of End Stage Lung Disease, and Other Pulmonary Pathologies in Vivo
Lung transplantation is indicated when end-stage lung diseases no longer respond to
available standard therapy, making life expectancy short and associated with disability.
Acute and chronic rejection are common complications following transplantation, indicating
screening bronchoscopies and transbronchial biopsies at three month intervals the first two
years, in addition to clinically indicated procedures when rejection or infection is
suspected. Transbronchial biopsies carry associated risks (bleeding, pneumothorax). Chronic
rejection is characterized by progressive obliteration of distal airways (Bronchiolitis
Obliterans-BO-). BO requires open lung biopsy for diagnosis. Alternatively, a clinical
surrogate (Bronchiolitis Obliterans Syndrome), characterized by decline in Forced Expired
Volume in 1 second not explained by acute rejection or infection is used for diagnosis. The
new technique of confocal endo-microscopy enables sub-surface visualization of tissue in
vivo during bronchoscopic procedures using a probe-based confocal microscope, integrated to
a standard endoscope. Bronchiolar and alveolar structures can be visualized at a cellular
and nuclear level, and these images can be saved and reviewed. This new technology could
potentially identify acute and chronic rejection, thus offering and alternative to
transbronchial biopsies. We expect to describe a new alternative to diagnose acute and
chronic rejection using confocal microscopy images obtained endoscopically, obviating
complications of transbronchial biopsies.
Endoscopic confocal endomicroscopy can detect and classify common bronchiolar and alveolar
pathological conditions in real time. Specifically, we hypothesize that confocal
endomicroscopy images of bronchiolar and alveolar structures during standard bronchoscopy
could help to recognize and classify the presence/absence of acute rejection and/or
bronchiolitis obliterans syndrome in lung transplant recipients. This technology could also
identify the histological characteristics lung diseases such as interstitial, obstructive or
vascular end stage lung diseases, and thus lead to more efficient, safer and more accurate
diagnosis of these lung conditions during routine bronchoscopies.
n/a
Observational Model: Case-Only, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05404919 -
Utilization of Hepatitis B Virus NAT+ Donors for Hepatitis B Vaccinated Lung Transplant Candidates
|
Phase 2 | |
Completed |
NCT03299504 -
Factors Predicting Success in Lung Transplant Recipients Who Have Undergone Intensive Post-operative Rehabilitation
|
||
Completed |
NCT00755781 -
Study of Cyclosporine Inhalation Solution (CIS) in Improving Bronchiolitis Obliterans Syndrome-Free Survival Following Lung Transplantation
|
Phase 3 | |
Recruiting |
NCT05547698 -
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
|
N/A | |
Terminated |
NCT03207399 -
Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
|
Phase 4 | |
Completed |
NCT03300882 -
PREDICT Cytomegalovirus (CMV)
|
||
Recruiting |
NCT05101460 -
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
|
||
Completed |
NCT03150095 -
Health Coaching to Improve Self-Management in Thoracic Transplant Candidates
|
N/A | |
Completed |
NCT04420195 -
Envarsus XR in Lung Transplant
|
Phase 2 | |
Recruiting |
NCT02235610 -
Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation
|
N/A | |
Not yet recruiting |
NCT06066229 -
Identification of Patient Important Outcomes in Lung Transplantation
|
||
Recruiting |
NCT04601818 -
Planned Semi-Elective Lung Tx Study
|
N/A | |
Recruiting |
NCT03072589 -
Study to Evaluate Adenosine 2A Receptor Agonist (Regadenoson) in Patients Undergoing Lung Transplantation
|
Phase 1 | |
Completed |
NCT01963780 -
International EXPAND Lung Pivotal Trial
|
N/A | |
Recruiting |
NCT05671887 -
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
|
||
Completed |
NCT03987113 -
Impact of Cold Ischemia on Pulmonary Endothelial Dysfunction in Ex-vivo Pulmonary Reconditioning
|
||
Recruiting |
NCT02748798 -
Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
|
Early Phase 1 | |
Completed |
NCT03167528 -
Contribution of Learning and Practice of Different Complementary Therapies in Pulmonary Transplant Patients
|
N/A | |
Active, not recruiting |
NCT04244734 -
Implementation of an Early Rehabilitation Program for the Patient With Lung Transplantation: From the ICU to Home.
|
N/A | |
Active, not recruiting |
NCT01365429 -
Novel Lung Trial: Normothermic Ex Vivo Lung Perfusion (Evlp) As An Assessment Of Extended/Marginal Donor Lungs
|
N/A |